2007-09-12T00:00:00
The summer witnessed another episode in the ongoing ‘rationing’ saga about NHS provision of the Alzheimer drugs rivastigmine, donepezil, and galantamine. The High Court upheld the substance of NICE’s guidance, which means that these drugs continue to be recommended only for people with ‘moderate’ Alzheimer’s.
With a HSJ subscription you’ll unlock:
HSJ is part of Wilmington Healthcare Limited. Company number 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 30158470
Site powered by Webvision Cloud